General - Press Releases

Date	Title	Company
10-Jan-2022	H3 Biomedicine Welcomes Dr. Richard Woodman to its Board of Directors	Businesswire
10-Jan-2022	Vaxiion Therapeutics Announces Clearance of IND Application for the Intralesional Administration of VAX014 to Subjects with Treatment Refractory Solid Tumors	Businesswire
10-Jan-2022	Tenaya Therapeutics Provides 2022 Business Updates	Businesswire
10-Jan-2022	ANJAC Health & Beauty joins forces with Canadian company APOLLO to expand its North American presence	Businesswire
10-Jan-2022	Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results	Businesswire
10-Jan-2022	NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation	Businesswire
10-Jan-2022	Pyramid Biosciences Appoints Brian Lestini, MD, PhD as Chief Executive Officer	Businesswire
10-Jan-2022	Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	VitalConnect Announces Closure of $39 Million Round of Growth Financing	Businesswire
10-Jan-2022	Puma Biotechnology Releases Updated Corporate Presentation	Businesswire
10-Jan-2022	Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases	Businesswire
10-Jan-2022	Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates	Businesswire
10-Jan-2022	Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results	Businesswire
10-Jan-2022	Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors	Businesswire
10-Jan-2022	Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies	Businesswire
10-Jan-2022	NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms	Businesswire
10-Jan-2022	Two Day Online Clinical Trial Regulatory Requirements Training Course (January 27-28, 2022) - ResearchAndMarkets.com	Businesswire
10-Jan-2022	Harrow Health to Participate in H.C. Wainwright BioConnect Conference	Businesswire
10-Jan-2022	Merck’s KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disease-Free Survival Versus Placebo as Adjuvant Treatment for Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless of PD-L1 Expression	Businesswire
10-Jan-2022	Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan’s 40th Annual Healthcare Conference	Businesswire